AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26831174 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric ropivacaine by the spinal route
Number of subjects: 20
Study 25157000 — intervention group
Group type: EXPERIMENTAL
Intervention: ATLAS intervention
Number of subjects: 361
Study 18670735 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 0
Study 18670735 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15359543 — intervention group
Group type: EXPERIMENTAL
Intervention: Test Dentifrice (1.0% hydrogen peroxide, 0.243% sodium fluoride, sodium tripolyphosphate in a high-cleaning silica base)
Number of subjects: 56
Study 15359543 — intervention group
Group type: COMPARATOR
Intervention: Positive Control Dentifrice (hexametaphosphate-containing whitening dentifrice)
Number of subjects: 56
Study 15359543 — intervention group
Group type: EXPERIMENTAL
Intervention: Test Dentifrice
Number of subjects: 56
Study 10675424 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-and-exercise group (restrict energy intake by 500 kcal/day and exercise for 45 minutes, 4 days/week)
Number of subjects: 40
Study 10675424 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintain usual dietary intake and exercise no more than once/week)
Number of subjects: 40
Study 10675424 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-and-exercise group
Number of subjects: 40
Study 10675424 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 9292561 — intervention group
Group type: EXPERIMENTAL
Intervention: Single intravenous dose of 750 mg of vancomycin administered 6 to 12 hours before the procedure
Number of subjects: 206
Study 9292561 — intervention group
Group type: COMPARATOR
Intervention: No vancomycin prophylaxis (control group)
Number of subjects: 206
Study 8501998 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral interventions intended to encourage testing
Number of subjects: 1565
Study 8501998 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1565
Study 8501998 — intervention group
Group type: EXPERIMENTAL
Intervention: First-round testing
Number of subjects: 1565
Study 8501998 — intervention group
Group type: EXPERIMENTAL
Intervention: First-round intervention
Number of subjects: 1565
Study 8501998 — intervention group
Group type: EXPERIMENTAL
Intervention: First-round adherence
Number of subjects: 1565
Study 8501998 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal FOBT result
Number of subjects: 1565
Study 2883908 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 30
Study 2883908 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 30
Study 30639763 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet-based screening
Number of subjects: 1818
Study 30639763 — intervention group
Group type: COMPARATOR
Intervention: Verbal interview screening
Number of subjects: 1818
Study 30639763 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall comfort level
Number of subjects: 1818
Study 30639763 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference for screening modality
Number of subjects: 1818
Study 28276987 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous cold water immersion (12 min at 12 ± 0.4°C)
Number of subjects: 10
Study 28276987 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent cold water immersion (4 x 2 min immersion at 12 ± 0.4 °C + 1 min out of water)
Number of subjects: 10
Study 28276987 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 10
Study 26484851 — intervention group
Group type: EXPERIMENTAL
Intervention: HCSU calendars
Number of subjects: 163
Study 26484851 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual surveys
Number of subjects: 163
Study 26484851 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveys with incentives (gift card)
Number of subjects: 163
Study 26484851 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean return interval for HCSU calendars
Number of subjects: 163
Study 26484851 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean return interval for surveys
Number of subjects: 163
Study 25388906 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine
Number of subjects: 760
Study 25388906 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulpadoxine/pyrimethamine-amodiaquine combination
Number of subjects: 760
Study 25388906 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulpadoxine/pyrimethamine
Number of subjects: 760
Study 25388906 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs in IL22
Number of subjects: 760
Study 25388906 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs in IL-4R1
Number of subjects: 760
Study 25388906 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs in CD36
Number of subjects: 760
Study 25388906 — intervention group
Group type: EXPERIMENTAL
Intervention: High fever (>39°C for 48 hours)
Number of subjects: 760
Study 25388906 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulani participants
Number of subjects: 760
Study 22678188 — intervention group
Group type: EXPERIMENTAL
Intervention: Radio ads
Number of subjects: 0
Study 19530940 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 118
Study 19530940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 17707753 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvanted vaccine (3.8 microg)
Number of subjects: 400
Study 17707753 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvanted vaccines (all doses)
Number of subjects: 400
Study 17707753 — intervention group
Group type: COMPARATOR
Intervention: Non-adjuvanted vaccines (all doses)
Number of subjects: 400
Study 17707753 — intervention group
Group type: EXPERIMENTAL
Intervention: All vaccine formulations
Number of subjects: 400
Study 15533143 — intervention group
Group type: EXPERIMENTAL
Intervention: ENT review at 1 week and 1 month (Group A)
Number of subjects: 66
Study 15533143 — intervention group
Group type: COMPARATOR
Intervention: ENT review at 1 month only (Group B)
Number of subjects: 66
Study 11589769 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine monotherapy (CsA)
Number of subjects: 37
Study 11589769 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus monotherapy
Number of subjects: 37
Study 11589769 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy (CAP)
Number of subjects: 37
Study 9458147 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (group I) with cold blood cardioplegia
Number of subjects: 14
Study 9458147 — intervention group
Group type: COMPARATOR
Intervention: Cold intermittent blood cardioplegia (group II)
Number of subjects: 14
Study 8201130 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light for 1 h daily for 2 weeks
Number of subjects: 26
Study 8201130 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-min exposure to light daily
Number of subjects: 26
Study 3295209 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (AMI)
Number of subjects: 95
Study 3295209 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (IMI)
Number of subjects: 95
Study 29357012 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglycolic acid (PGA) sheets and fibrin glue
Number of subjects: 84
Study 29357012 — intervention group
Group type: COMPARATOR
Intervention: ESD only (Control)
Number of subjects: 84
Study 26946958 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 Hz-tACS
Number of subjects: 25
Study 26946958 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 Hz-tACS
Number of subjects: 25
Study 26946958 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz-tACS
Number of subjects: 25
Study 26946958 — intervention group
Group type: COMPARATOR
Intervention: sham-tACS
Number of subjects: 25
Study 24799686 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (trained in meditation, breathing techniques, and cold exposure)
Number of subjects: 24
Study 24799686 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 24
Study 24799686 — intervention group
Group type: COMPARATOR
Intervention: Control group (not trained)
Number of subjects: 24
Study 24799686 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 23530729 — intervention group
Group type: EXPERIMENTAL
Intervention: Foley catheter
Number of subjects: 819
Study 23530729 — intervention group
Group type: COMPARATOR
Intervention: Prostaglandin E₂ gel
Number of subjects: 819
Study 20419525 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine for adjunctive treatment of anorexia nervosa
Number of subjects: 92
Study 19902046 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing only (Group A)
Number of subjects: 45
Study 19902046 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing followed by systemic doxycycline (Group B)
Number of subjects: 45
Study 19902046 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control Group C)
Number of subjects: 45
Study 16909188 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral trimethoprim (TMP) 5 mg/kg
Number of subjects: 0
Study 16909188 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral trimethoprim (TMP) 10 mg/kg
Number of subjects: 0
Study 16909188 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral trimethoprim (TMP) 20 mg/kg
Number of subjects: 0
Study 16909188 — intervention group
Group type: EXPERIMENTAL
Intervention: Second dose of oral TMP 5 mg/kg
Number of subjects: 0
Study 16909188 — intervention group
Group type: EXPERIMENTAL
Intervention: Second dose of oral TMP 10 mg/kg
Number of subjects: 0
Study 15072506 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg/day (n = 15)
Number of subjects: 29
Study 15072506 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 14)
Number of subjects: 29
Study 11035692 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic thoracentesis
Number of subjects: 20
Study 11035692 — intervention group
Group type: EXPERIMENTAL
Intervention: Tube thoracostomy
Number of subjects: 20
Study 11035692 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinolytics
Number of subjects: 20
Study 11035692 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic surgery (VATS)
Number of subjects: 20
Study 11035692 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (including thoracotomy with or without decortication and rib resection)
Number of subjects: 20
Study 11035692 — intervention group
Group type: COMPARATOR
Intervention: No drainage performed
Number of subjects: 20
Study 11035692 — intervention group
Group type: COMPARATOR
Intervention: Control group (no drainage)
Number of subjects: 20
Study 8818070 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group with a 2.4% reduction in total fat intake
Number of subjects: 1182
Study 8818070 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1182
Study 8818070 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 1182
Study 1568369 — intervention group
Group type: EXPERIMENTAL
Intervention: Metadoxine (500 mg twice a day)
Number of subjects: 72
Study 1568369 — intervention group
Group type: COMPARATOR
Intervention: Control group (vitamins)
Number of subjects: 72
Study 1568369 — intervention group
Group type: EXPERIMENTAL
Intervention: Metadoxine
Number of subjects: 72
Study 3904379 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 127
Study 3904379 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 127
Study 31064374 — intervention group
Group type: EXPERIMENTAL
Intervention: Watching a short film about a negative event relating to depression (experimental group)
Number of subjects: 180
Study 31064374 — intervention group
Group type: COMPARATOR
Intervention: Watching a short film about a negative event without relation to depression (control group 1)
Number of subjects: 180
Study 31064374 — intervention group
Group type: COMPARATOR
Intervention: Watching a neutral event relating to depression (control group 2)
Number of subjects: 180
Study 30300099 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) - 8-10 sessions of red and infrared lasers over the flexor tendon repaired area
Number of subjects: 97
Study 30300099 — intervention group
Group type: COMPARATOR
Intervention: Control group (no LLLT)
Number of subjects: 97
Study 26871651 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 283
Study 26871651 — intervention group
Group type: COMPARATOR
Intervention: Prolonged conservative care
Number of subjects: 283
Study 26871651 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI assessment of nerve root compression
Number of subjects: 283
Study 26871651 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI assessment of extrusion vs protrusion of disc herniation
Number of subjects: 283
Study 26871651 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI findings
Number of subjects: 283
Study 23744513 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA (50 mg/day) + COC (20 µg ethinyl estradiol/0.1 mg levonorgestrel)
Number of subjects: 80
Study 22413782 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (20 schools)
Number of subjects: 2156
Study 22413782 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 schools)
Number of subjects: 2156
Study 20134374 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil
Number of subjects: 50
Study 20134374 — intervention group
Group type: COMPARATOR
Intervention: Intravenous sufentanil
Number of subjects: 50
Study 17432701 — intervention group
Group type: EXPERIMENTAL
Intervention: Arteriojugular venous differences of lactate (AVDL)
Number of subjects: 45
Study 17432701 — intervention group
Group type: COMPARATOR
Intervention: Cerebral lactate concentration (gold standard)
Number of subjects: 45
Study 16238653 — intervention group
Group type: EXPERIMENTAL
Intervention: Magic trick distraction (Magic+)
Number of subjects: 70
Study 16238653 — intervention group
Group type: COMPARATOR
Intervention: Tell-show-do (TSD) (Magic-)
Number of subjects: 70
Study 11870439 — intervention group
Group type: COMPARATOR
Intervention: Storage-phosphor technology (SPT) at standard dose (speed class S400, n=25)
Number of subjects: 75
Study 11870439 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose FDT (S400, n=25)
Number of subjects: 75
Study 11870439 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose FDT (S800, n=25)
Number of subjects: 75
Study 9535527 — intervention group
Group type: EXPERIMENTAL
Intervention: Weak SCI subjects
Number of subjects: 28
Study 9535527 — intervention group
Group type: COMPARATOR
Intervention: Nonweak SCI subjects
Number of subjects: 28
Study 9535527 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 28
Study 7624386 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 19
Study 7624386 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulpiride
Number of subjects: 19
Study 2695384 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation
Number of subjects: 8
Study 330825 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 18
Study 330825 — intervention group
Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 18
Study 30699039 — intervention group
Group type: EXPERIMENTAL
Intervention: LARS procedure
Number of subjects: 47
Study 30699039 — intervention group
Group type: COMPARATOR
Intervention: MBG procedure
Number of subjects: 47
Study 26318373 — intervention group
Group type: EXPERIMENTAL
Intervention: Jejunostomy feeding tube (JFT)
Number of subjects: 15
Study 26161664 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral tDCS with right prefrontal anodal and left prefrontal cathodal montage
Number of subjects: 69
Study 26161664 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral tDCS with left prefrontal anodal and right prefrontal cathodal montage
Number of subjects: 69
Study 26161664 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control group)
Number of subjects: 69
Study 23121460 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + boric acid irrigation (0.75%)
Number of subjects: 45
Study 23121460 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + chlorhexidine irrigation (CHX)
Number of subjects: 45
Study 23121460 — intervention group
Group type: COMPARATOR
Intervention: SRP + saline irrigation (C)
Number of subjects: 45
Study 20673253 — intervention group
Group type: EXPERIMENTAL
Intervention: Heel cup
Number of subjects: 51
Study 20673253 — intervention group
Group type: COMPARATOR
Intervention: Heel wedge
Number of subjects: 51
Study 20673253 — intervention group
Group type: EXPERIMENTAL
Intervention: Heel cup (preference)
Number of subjects: 51
Study 20673253 — intervention group
Group type: EXPERIMENTAL
Intervention: Insole use at 1-year follow-up
Number of subjects: 51
Study 19736502 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumoral muscle exercises
Number of subjects: 0
Study 19736502 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 16434453 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg rhTSH
Number of subjects: 10
Study 16434453 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 10
Study 15487684 — intervention group
Group type: EXPERIMENTAL
Intervention: Residential indoor PM2.5
Number of subjects: 178
Study 15487684 — intervention group
Group type: EXPERIMENTAL
Intervention: Residential outdoor PM2.5
Number of subjects: 178
Study 15487684 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace indoor PM2.5
Number of subjects: 178
Study 15487684 — intervention group
Group type: COMPARATOR
Intervention: Outdoor fixed-site monitoring
Number of subjects: 178
Study 10682941 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic walking
Number of subjects: 103
Study 10682941 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight training
Number of subjects: 103
Study 10682941 — intervention group
Group type: COMPARATOR
Intervention: Health education control
Number of subjects: 103
Study 9480565 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate (300, 600, or 1200 mg)
Number of subjects: 150
Study 9480565 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (infusion 1.6 mg/h for 6 h)
Number of subjects: 150
Study 9480565 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate and Naloxone
Number of subjects: 150
Study 7909705 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine (5 mg) plus Metoprolol (50 mg)
Number of subjects: 6
Study 7909705 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (20 mg) plus Atenolol (50 mg)
Number of subjects: 6
Study 3781700 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambroxol (1.5‐2.0 mg/kg body weight orally)
Number of subjects: 120
Study 3781700 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 2826066 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine 20 mg
Number of subjects: 12
Study 2826066 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 12
Study 2826066 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine
Number of subjects: 12
Study 2826066 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 12
Study 31845203 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial clinical assessment including sex, symptom reporting, and physiological predominant symptom cluster
Number of subjects: 568
Study 31845203 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 568
Study 31845203 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Positive Symptom Total at initial assessment
Number of subjects: 568
Study 31845203 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological predominant symptom cluster
Number of subjects: 568
Study 31297674 — intervention group
Group type: EXPERIMENTAL
Intervention: Magtrace (magnetic tracer)
Number of subjects: 146
Study 31297674 — intervention group
Group type: COMPARATOR
Intervention: Standard technique (radioisotope and blue dye)
Number of subjects: 146
Study 31297674 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 146
Study 28629344 — intervention group
Group type: EXPERIMENTAL
Intervention: ONO-5334 100 mg QD
Number of subjects: 0
Study 28629344 — intervention group
Group type: EXPERIMENTAL
Intervention: ONO-5334 300 mg QD
Number of subjects: 0
Study 28629344 — intervention group
Group type: EXPERIMENTAL
Intervention: ONO-5334 50 mg BID
Number of subjects: 0
Study 28629344 — intervention group
Group type: COMPARATOR
Intervention: Comparison of ONO-5334 50 mg BID vs. 100 mg QD
Number of subjects: 0
Study 25443461 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (BVZ)
Number of subjects: 45
Study 25443461 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C (MMC)
Number of subjects: 45
Study 23647406 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga Nidra (35-40 minutes/day, five times/week for 6 months)
Number of subjects: 150
Study 21515892 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular Socket System (MSS)
Number of subjects: 20
Study 21515892 — intervention group
Group type: COMPARATOR
Intervention: standard laminated socket (PC)
Number of subjects: 20
Study 17999174 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin
Number of subjects: 114
Study 17999174 — intervention group
Group type: EXPERIMENTAL
Intervention: B-complex vitamin
Number of subjects: 114
Study 17999174 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo vitamin
Number of subjects: 114
Study 17999174 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 114
Study 16776894 — intervention group
Group type: EXPERIMENTAL
Intervention: Special intervention (individual counseling visit, twelve group sessions, three postcard messages, twelve monthly telephone calls)
Number of subjects: 201
Study 16776894 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention (control group)
Number of subjects: 201
Study 12830438 — intervention group
Group type: EXPERIMENTAL
Intervention: Short daily hemodialysis
Number of subjects: 23
Study 12830438 — intervention group
Group type: EXPERIMENTAL
Intervention: Long nocturnal hemodialysis
Number of subjects: 23
Study 12830438 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional hemodialysis)
Number of subjects: 23
Study 11081529 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment isoniazid prophylaxis
Number of subjects: 233